Application of carbon nanoparticle suspension injection-fe in combined administration

Abstract

Provided is an application of carbon nanoparticle suspension injection-Fe in combined administration. The combined administration of the carbon nanoparticle suspension injection-Fe and anticancer drugs is used for inhibiting tumor growth, the anticancer drugs are orally and intravenously administered, and the carbon nanoparticle suspension injection-Fe is administrated through intratumoral injection. After the carbon nanoparticle suspension injection-Fe is injected into a tumor, the carbon nanoparticle suspension injection-Fe has the effect of enriching the anticancer drugs orally or intravenously administered into the tumor, improving concentrations of the anticancer drugs in the tumor, such that the anticancer drugs are enabled to act more accurately on a tumor site, doses and toxic and side effects on normal cells and tissues are relatively reduced, and after the combined administration of the carbon nanoparticle suspension injection-Fe and the anticancer drugs, a synergistic effect is achieved, thereby achieving a better anticancer curative effect.

Dependencies are inferred from the claim text.